Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-200
Closed 2440
2023
Q4
$0 Buy
+200
New +$475 ﹤0.01% 3681
2018
Q4
Sell
-500
Closed -$14K 3990
2018
Q3
$14K Sell
500
-162
-24% -$4.65K ﹤0.01% 2445
2018
Q2
$18K Buy
662
+562
+562% +$16.7K ﹤0.01% 2252
2018
Q1
$3K Sell
100
-1,500
-94% -$47.4K ﹤0.01% 3536
2017
Q4
$46K Buy
1,600
+1,379
+624% +$37.6K ﹤0.01% 1924
2017
Q3
$6K Sell
221
-600
-73% -$15.5K ﹤0.01% 4193
2017
Q2
$21K Buy
+821
New +$19.6K ﹤0.01% 3357
2016
Q4
Sell
-100
Closed -$1.85K 6578
2016
Q3
$2K Buy
+100
New +$2.61K ﹤0.01% 5646

Other funds holding CLLS

Cutler Group's CLLS Position: Q1 2024 in Review

Cutler Group sold out of Cellectis (CLLS) in Q1 2024, closing a stake of 200 shares.

Cutler Group first reported a position in CLLS in Q3 2016 and held it in 8 quarters. The position peaked at $46K in Q4 2017. 31 funds tracked by Wall St. Rank hold CLLS as of Q1 2024.

  • Cutler Group reported no remaining Cellectis position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 200 Cellectis shares in Q1 2024.
  • Cutler Group first reported a position in Cellectis in Q3 2016 and held it in 8 quarters.
  • Cutler Group's Cellectis position peaked at $46K in Q4 2017.
  • 31 funds tracked by Wall St. Rank held Cellectis as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.